Shares of NantKwest, Inc. (NASDAQ:NK) have been assigned an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $11.40.
Several equities analysts recently weighed in on NK shares. Zacks Investment Research upgraded NantKwest from a “hold” rating to a “buy” rating and set a $7.75 price target for the company in a research note on Saturday, June 24th. Jefferies Group LLC set a $4.00 price objective on NantKwest and gave the stock a “hold” rating in a report on Monday, May 8th. BidaskClub cut NantKwest from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. ValuEngine upgraded NantKwest from a “strong sell” rating to a “sell” rating in a report on Wednesday, June 14th. Finally, Citigroup Inc. cut NantKwest from a “neutral” rating to a “sell” rating and set a $3.00 price objective on the stock. in a report on Monday, May 15th.
COPYRIGHT VIOLATION WARNING: This piece was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/08/10/brokerages-set-nantkwest-inc-nasdaqnk-pt-at-11-40-updated.html.
Shares of NantKwest (NASDAQ NK) traded down 6.933% during trading on Friday, hitting $5.705. The stock had a trading volume of 113,941 shares. NantKwest has a 52 week low of $2.71 and a 52 week high of $9.60. The firm has a 50 day moving average price of $6.91 and a 200-day moving average price of $4.88. The stock’s market capitalization is $453.21 million.
In related news, Director Steve Gorlin sold 40,000 shares of the business’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $7.78, for a total transaction of $311,200.00. Following the completion of the transaction, the director now owns 409,725 shares in the company, valued at $3,187,660.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 70.19% of the stock is currently owned by corporate insiders.
Several large investors have recently made changes to their positions in NK. Vident Investment Advisory LLC boosted its position in NantKwest by 20.0% in the first quarter. Vident Investment Advisory LLC now owns 138,691 shares of the biotechnology company’s stock valued at $492,000 after buying an additional 23,112 shares in the last quarter. Tudor Investment Corp Et Al purchased a new position in NantKwest during the fourth quarter valued at about $102,000. Renaissance Technologies LLC purchased a new position in NantKwest during the fourth quarter valued at about $140,000. Dynamic Technology Lab Private Ltd boosted its position in shares of NantKwest by 53.4% in the first quarter. Dynamic Technology Lab Private Ltd now owns 32,939 shares of the biotechnology company’s stock worth $117,000 after buying an additional 11,465 shares during the period. Finally, Teachers Advisors LLC boosted its position in shares of NantKwest by 53.6% in the fourth quarter. Teachers Advisors LLC now owns 40,507 shares of the biotechnology company’s stock worth $232,000 after buying an additional 14,131 shares during the period. Institutional investors and hedge funds own 19.75% of the company’s stock.
NantKwest Company Profile
Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
